Related Experiment Video
Updated: Aug 7, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Cefepime (maxipime) in the treatment of severe urinary tract infection]
1Research Insitute of Urology, Ministry of Public Health of the Russian Federation, Moscow.
Abstract:
Comparative susceptibility of microflora isolates from patients with complicated urinary tract infections to cefepime, other cephalosporins, amikacin, ciprofloxacin and ofloxacin was studied. Isolates in the diagnostic titers (5 x 10(4)-5 x 10(8)) from the patients treated with cefepime as etiotropic monotherapy were identified. The treatment course was 7 to 14 days. The daily dose was 1 to 2 g. The clinical and bacteriological efficacies of the cefepime therapy equaled to 93.2 and 85.4% respectively.
Insights
Cefepime demonstrated high clinical and bacteriological efficacy in treating complicated urinary tract infections (cUTIs). This study compared its effectiveness against other antibiotics, finding it a successful monotherapy option for cUTI patients.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Complicated urinary tract infections (cUTIs) pose a significant clinical challenge.
- Antimicrobial resistance necessitates evaluation of effective treatment options.
Purpose of the Study:
- To compare the susceptibility of microflora isolates from cUTI patients to cefepime and other antibiotics.
- To evaluate the clinical and bacteriological efficacy of cefepime monotherapy in treating cUTIs.
Main Methods:
- Microflora isolates from cUTI patients were identified.
- Susceptibility testing was performed for cefepime, other cephalosporins, amikacin, ciprofloxacin, and ofloxacin.
- Patients received cefepime monotherapy (1-2g daily) for 7-14 days.
Main Results:
- Cefepime exhibited high clinical efficacy at 93.2%.
- Bacteriological efficacy of cefepime was 85.4%.
- Isolates were identified within diagnostic titers ranging from 5 x 10(4) to 5 x 10(8).
Conclusions:
- Cefepime is an effective etiotropic monotherapy for complicated urinary tract infections.
- The study supports the use of cefepime in managing cUTIs based on its high efficacy rates.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Urine Studies II: Urine Culture and Sensitivity Test
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis

